Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22.7M
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
20.1M
-
Shares change
-
+604K
-
Total reported value, excl. options
-
$1.14B
-
Value change
-
+$34.7M
-
Put/Call ratio
-
0.04
-
Number of buys
-
115
-
Number of sells
-
-89
-
Price
-
$56.76
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q4 2023
253 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q4 2023.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.1M shares
of 22.7M outstanding shares and own 88.58% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.3M shares), Conestoga Capital Advisors, LLC (1.93M shares), VANGUARD GROUP INC (1.55M shares), Copeland Capital Management, LLC (1.26M shares), Ranger Investment Management, L.P. (913K shares), GENEVA CAPITAL MANAGEMENT LLC (905K shares), STATE STREET CORP (797K shares), DIMENSIONAL FUND ADVISORS LP (671K shares), CONGRESS ASSET MANAGEMENT CO /MA (595K shares), and GEODE CAPITAL MANAGEMENT, LLC (459K shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.